Covid-19: Vaccine makers asked to submit more data

The drug regulator has asked Bharat Biotech and Serum Institute of India (SII), which have sought emergency use authorisation (EUA) for their anti-Covid vaccines, to submit updated safety and immunogenicity data from Phase-3 trials being held in India, official sources said.The drug regulator has asked Bharat Biotech and Serum Institute of India (SII), which have sought emergency use authorisation (EUA) for their anti-Covid vaccines, to submit updated safety and immunogenicity data from Phase-3 trials being held in India, official sources said.